UB Paderborn / Katalog / Suche / in CDI

Safety and Efficacy of Anastrozole for the Treatment of Pubertal Gynecomastia: A Randomized, Double-Blind, Placebo-Controlled Trial

The journal of clinical endocrinology and metabolism, 2004-09, Vol.89 (9), p.4428-4433

2004

Link zum Volltext

Verfügbarkeit prüfen

Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia

Annals of the New York Academy of Sciences, 2014-11, Vol.1329 (1), p.81-92

2014

Link zum Volltext

Verfügbarkeit prüfen

Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial

Pediatric blood & cancer, 2014-07, Vol.61 (7), p.1232-1238

2014

Link zum Volltext

Verfügbarkeit prüfen

Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia

Pediatric blood & cancer, 2016-02, Vol.63 (2), p.228-233

2016

Link zum Volltext

Verfügbarkeit prüfen

Open-label, phase 2, multicenter study of lasofoxifene (LAS) combined with abemaciclib (Abema) for treating pre- and postmenopausal women with locally advanced or metastatic ER+/HER2− breast cancer and an ESR1 mutation after progression on prior therapies

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1022-1022

2022

Link zum Volltext

Verfügbarkeit prüfen

Arimidex : A potent and selective fourth-generation aromatase inhibitor

Breast cancer research and treatment, 1994, Vol.30 (1), p.103-111

1994

Link zum Volltext

Verfügbarkeit prüfen

Abstract OT-09-01: An open-label, multicenter study evaluating the safety of lasofoxifene in combination with abemaciclib for the treatment of pre and postmenopausal women with locally advanced or metastatic ER+/HER2− breast cancer and have an ESR1 mutation

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.OT-09-01-OT-09-01

2021

Link zum Volltext

Verfügbarkeit prüfen

The evolution of legislation to regulate pediatric clinical trials: Present and continuing challenges

Advanced drug delivery reviews, 2006-04, Vol.58 (1), p.106-115

2006

Link zum Volltext

Verfügbarkeit prüfen

Lasofoxifene (LAS) plus abemaciclib (Abema) for treating ESR1 -mutated ER+/HER2- metastatic breast cancer (mBC) after progression on prior therapies: ELAINE 2 study update

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1057-1057

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-05-02: Estrogen receptor 1 (ESR1) mutations in circulating tumor DNA (ctDNA) from patients with ER+/HER2- metastatic breast cancer (mBC) treated with lasofoxifene plus abemaciclib in the ELAINE 2 study

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P5-P5-05-02

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-05-04: Estrogen receptor 1 (ESR1) mutations in circulating tumor DNA (ctDNA) from patients with ER+/HER2- metastatic breast cancer (mBC) treated with lasofoxifene or fulvestrant in the ELAINE 1 study

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P5-P5-05-04

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety of asparaginase Erwinia chrysanthemi in a compassionate-use trial: Subanalysis of the adolescent/young adult (AYA) and adult patient (Pt) population

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.7097-7097

2013

Link zum Volltext

Verfügbarkeit prüfen

L-Asparaginase (L-ASP) Related Toxicities with Asparaginase Erwinia Chrysanthemi in a Large Compassionate Use Protocol

Blood, 2012-11, Vol.120 (21), p.2568-2568

2012

Link zum Volltext

Verfügbarkeit prüfen

The evolution of legislation to regulate pediatric clinical trials : Present and continuing challenges: Challenges in pediatric drug delivery: the case of vaccines

Advanced drug delivery reviews, 2006, Vol.58 (1), p.106-115

2006

Link zum Volltext

Verfügbarkeit prüfen

Administration of Erwinia Asparaginase (Erwinase®) Following Allergy to PEG-Asparaginase In Children and Young Adults with Acute Lymphoblastic Leukemia Treated on AALL07P2 Achieves Therapeutic Nadir Serum Asparaginase Activity: A Report From the Children's Oncology Group (COG)

Blood, 2010-11, Vol.116 (21), p.2134-2134

2010

Link zum Volltext

Verfügbarkeit prüfen

ARIMIDEX ™: A new oral, once-a-day aromatase inhibitor

Journal of steroid biochemistry and molecular biology, 1995-06, Vol.53 (1), p.175-179

1995

Link zum Volltext

Verfügbarkeit prüfen

ARIMIDEX: a potent and selective aromatase inhibitor for the treatment of advanced breast cancer

Journal of steroid biochemistry and molecular biology, 1997-04, Vol.61 (3), p.145-149

1997

Link zum Volltext

Verfügbarkeit prüfen

Response to commentary on endometrial cancer deaths in tamoxifen-treated breast cancer patients

Journal of clinical oncology, 1996-10, Vol.14 (10), p.2886-2887

1996

Link zum Volltext

Verfügbarkeit prüfen

Clomiphene in the treatment of adolescent gynecomastia. Clinical and endocrine studies

American journal of diseases of children (1960), 1983-11, Vol.137 (11), p.1080

1983

Link zum Volltext

Verfügbarkeit prüfen

Thallium-technetium parathyroid scan. A useful noninvasive technique for localization of abnormal parathyroid tissue

Archives of internal medicine (1960), 1986-06, Vol.146 (6), p.1077

1986

Link zum Volltext

Verfügbarkeit prüfen

Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer

Journal of clinical oncology, 1994-01, Vol.12 (1), p.50-54

1994

Link zum Volltext

Verfügbarkeit prüfen

Impotence associated with low biological to immunological ratio of luteinizing hormone in a man with a pituitary stone

The journal of clinical endocrinology and metabolism, 1985-04, Vol.60 (4), p.797-802

1985

Link zum Volltext

Verfügbarkeit prüfen

Intrasellar mixed germ-cell tumor. Case report

Journal of neurosurgery, 1983-05, Vol.58 (5), p.766

1983

Link zum Volltext

Verfügbarkeit prüfen

Acanthosis nigricans and insulin resistance

Journal of the American Academy of Dermatology, 1984-05, Vol.10 (5), p.887-891

1984

Link zum Volltext

Verfügbarkeit prüfen

Home care providers' perceptions of shared decision‐making with older clients (and their caregivers): A cross‐sectional study

Nursing & health sciences, 2022-06, Vol.24 (2), p.487-498

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Safety and Efficacy of Anastrozole for the Treatment of Pubertal Gynecomastia: A Randomized, Double-Blind, Placebo-Controlled Trial

Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia

Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial

Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia

Open-label, phase 2, multicenter study of lasofoxifene (LAS) combined with abemaciclib (Abema) for treating pre- and postmenopausal women with locally advanced or metastatic ER+/HER2− breast cancer and an ESR1 mutation after progression on prior therapies

Arimidex : A potent and selective fourth-generation aromatase inhibitor

Abstract OT-09-01: An open-label, multicenter study evaluating the safety of lasofoxifene in combination with abemaciclib for the treatment of pre and postmenopausal women with locally advanced or metastatic ER+/HER2− breast cancer and have an ESR1 mutation

The evolution of legislation to regulate pediatric clinical trials: Present and continuing challenges

Lasofoxifene (LAS) plus abemaciclib (Abema) for treating ESR1 -mutated ER+/HER2- metastatic breast cancer (mBC) after progression on prior therapies: ELAINE 2 study update

Abstract P5-05-02: Estrogen receptor 1 (ESR1) mutations in circulating tumor DNA (ctDNA) from patients with ER+/HER2- metastatic breast cancer (mBC) treated with lasofoxifene plus abemaciclib in the ELAINE 2 study

Abstract P5-05-04: Estrogen receptor 1 (ESR1) mutations in circulating tumor DNA (ctDNA) from patients with ER+/HER2- metastatic breast cancer (mBC) treated with lasofoxifene or fulvestrant in the ELAINE 1 study

Safety of asparaginase Erwinia chrysanthemi in a compassionate-use trial: Subanalysis of the adolescent/young adult (AYA) and adult patient (Pt) population

L-Asparaginase (L-ASP) Related Toxicities with Asparaginase Erwinia Chrysanthemi in a Large Compassionate Use Protocol

The evolution of legislation to regulate pediatric clinical trials : Present and continuing challenges: Challenges in pediatric drug delivery: the case of vaccines

Administration of Erwinia Asparaginase (Erwinase®) Following Allergy to PEG-Asparaginase In Children and Young Adults with Acute Lymphoblastic Leukemia Treated on AALL07P2 Achieves Therapeutic Nadir Serum Asparaginase Activity: A Report From the Children's Oncology Group (COG)

ARIMIDEX ™: A new oral, once-a-day aromatase inhibitor

ARIMIDEX: a potent and selective aromatase inhibitor for the treatment of advanced breast cancer

Response to commentary on endometrial cancer deaths in tamoxifen-treated breast cancer patients

Clomiphene in the treatment of adolescent gynecomastia. Clinical and endocrine studies

Thallium-technetium parathyroid scan. A useful noninvasive technique for localization of abnormal parathyroid tissue

Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer

Impotence associated with low biological to immunological ratio of luteinizing hormone in a man with a pituitary stone

Intrasellar mixed germ-cell tumor. Case report

Acanthosis nigricans and insulin resistance

Home care providers' perceptions of shared decision‐making with older clients (and their caregivers): A cross‐sectional study

Suchergebnisse filtern